NVS Gets Positive CHMP Opinion for Cosentyx for Another Indication

RegulatorypositiveCosentyxPositive

AI Analysis

Summary

Novartis received a positive Committee for Medicinal Products for Human Use (CHMP) opinion for Cosentyx for an additional indication, supporting potential European regulatory approval.

Outcome Details

Positive CHMP opinion for another indication

Importance:7/10

Sentiment:

0.70

regulatoryCHMPCosentyxexpansion indicationEuropean approval pathway

Related Companies

$NVS

Read the original article

Published by yahoo_finance on September 21, 2026 3:57 PM

Read Original